$HTBX  announced that the first patient has been treated in the Company's first-in-human Phase 1 clinical trial evaluating PTX-35, the first antibody product candidate developed by  Heat Biologics ' Pelican Therapeutics subsidiary.

#daytrading #stocks #pennystocks